Feasibility Study of External Beam Radiotherapy and Iodine-131 Tositumomab (Bexxar) for Patients With Relapsed Follicular Non-Hodgkin's Lymphoma.
Latest Information Update: 25 Jun 2023
At a glance
- Drugs Iodine-131 tositumomab (Primary)
- Indications Follicular lymphoma
- Focus Adverse reactions
- 14 Feb 2012 Planned end date 1 Apr 2009 added as reported by ClinicalTrials.gov.
- 14 Feb 2012 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 30 Aug 2011 Additional lead investigator identified as reported by ClinicalTrials.gov.